Copper radionuclides and radiopharmaceuticals in nuclear medicine
- 1 November 1996
- journal article
- review article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 23 (8) , 957-980
- https://doi.org/10.1016/s0969-8051(96)00130-8
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- A Comparison of Copper Uptake by Liver Plasma Membrane Vesicles and Uptake by Isolated Cultured Rat HepatocytesHepatology, 1994
- Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imagingNuclear Medicine and Biology, 1993
- Design, synthesis and 64Cu labeling of fatty acid analogs containing dithiosemicarbazone chelateInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1989
- Evidence for a square scheme involving conformational intermediates in electron-transfer reactions of copper(II)/(I) systemsJournal of the American Chemical Society, 1989
- Similar Lethal Effect in Mammalian Cells for Two Radioisotopes of Copper with Different Decay Schemes,64Cu and67CuInternational Journal of Radiation Biology, 1989
- Phosphines and metal phosphine complexes: Relationship of chemistry to anticancer and other biological activityPublished by Springer Nature ,1988
- Differences in the consequences of the decay of radioactive64Cu atoms incorporated in cells under either in vitro or in vivo conditionsRadiation and Environmental Biophysics, 1987
- Thiolato-complexes of the transition metalsCoordination Chemistry Reviews, 1987
- Immobile- and mobile-phase ESR spectroscopy of copper complexes: studies on biologically interesting bis(thiosemicarbazonato)copper(II) chelatesInorganic Chemistry, 1984
- Combined modality of 2-formylpyridine monothiosemicarbazonato copper(II) and radiationInternational Journal of Radiation Oncology*Biology*Physics, 1981